Staging of Differentiated Thyroid Carcinoma: Standardizing Rational Thought Robert Udelsman Letter to the Editor 10 February 2007 Pages: 1521 - 1522
Surgical Management of Familial Hyperparathyroidism Douglas B. EvansThereasa A. RichGilbert J. Cote Editorial 07 February 2007 Pages: 1525 - 1527
Local Recurrence in Soft Tissue Sarcoma: More About the Tumor, Less About the Surgeon Murray F. Brennan Editorial Review 13 February 2007 Pages: 1528 - 1529
How Does It Feel? Sentinel Node Biopsy Is Better Craig D. Shriver Editorial 03 April 2007 Pages: 1530 - 1531
Non-Inferiority Trials in Surgical Oncology Philipp FueglistalerMichel AdaminaUlrich Guller ContinuingEducation 09 February 2007 Pages: 1532 - 1539
Magnetic Resonance–Guided Focused Ultrasound Surgery for the Noninvasive Curative Ablation of Tumors and Palliative Treatments: A Review Doron KopelmanMoshe Papa Educational Review 21 February 2007 Pages: 1540 - 1550
Restaging of Differentiated Thyroid Carcinoma by the Sixth Edition AJCC/UICC TNM Staging System: Stage Migration and Predictability Brian LangChung-Yau LoKoon-Yat Wan Endocrine Tumors 21 February 2007 Pages: 1551 - 1559
Review of Distribution of Nodal Disease in Differentiated Thyroid Cancers in an Oncosurgical Center in Sri Lanka Indranee Y. AmarasingheNaomal M. A. PereraA.K.C. Peiris OriginalPaper 21 February 2007 Pages: 1560 - 1564
Change of E-Cadherin by Hepatocyte Growth Factor and Effects on the Prognosis of Hypopharyngeal Carcinoma Chul-Ho KimJangHee KimEun Chang Choi Head 10 February 2007 Pages: 1565 - 1574
Carcinoma Metastatic to Cervical Lymph Nodes From an Occult Primary Tumor: The Outcome After Combined-Modality Therapy Paolo Boscolo-RizzoAlessandro GavaMaria Cristina Da Mosto Head and Neck 16 February 2007 Pages: 1575 - 1582
Extremity Soft Tissue Sarcoma: Adding to the Prognostic Meaning of Local Failure Alessandro GronchiRosalba MiceliPaolo G. Casali Bone and Soft Tissue Sarcomas 28 January 2007 Pages: 1583 - 1590
The Pedicled Latissimus Dorsi Flap for Shoulder Reconstruction After Sarcoma Resection Amir Babak BehnamConstance M. ChenPeter G. Cordeiro Bone and Soft Tissue Sarcomas 10 February 2007 Pages: 1591 - 1595
Regional Nodal Metastatic Disease Is the Strongest Predictor of Survival in Patients with Thin Vertical Growth Phase Melanomas: A Case for SLN Staging Biopsy in These Patients Giorgos C. KarakousisPhyllis A. GimottyFrancis R. Spitz Melanomas 07 February 2007 Pages: 1596 - 1603
Natural History of Melanoma in 773 Patients with Tumor-Negative Sentinel Lymph Nodes Theresa G. ZogakisRichard EssnerDonald L. Morton OriginalPaper 01 March 2007 Pages: 1604 - 1611
Intraoperative Evaluation of Sentinel Lymph Nodes for Metastatic Melanoma by Imprint Cytology Victoria SooPerry ShenEdward A. Levine OriginalPaper 09 February 2007 Pages: 1612 - 1617
Factors Affecting Successful Breast Conservation for Ductal Carcinoma in Situ Mary F. DillonEnda W. Mc DermottNiall O’Higgins Breast Oncology 14 February 2007 Pages: 1618 - 1628
Breast Cancer Sentinel Lymph Node Identification Rates: The Influence of Radiocolloid Mapping, Case Volume, and the Place of the Procedure S. David NathansonJennifer K. GroganKastytis Karvelis Breast Oncology 26 January 2007 Pages: 1629 - 1637
Results of 23,810 Cases of Ductal Carcinoma-in-situ William E. Sumner IIILeonidas G. KoniarisDido Franceschi OriginalPaper 24 January 2007 Pages: 1638 - 1643
A Phase II Trial of Image-Guided Radiofrequency Ablation of Small Invasive Breast Carcinomas: Use of Saline-Cooled Tip Electrode Vijay P. KhatriJohn P. McGahanStephen Wilkendorf Breast Oncology 15 February 2007 Pages: 1644 - 1652
Eighteen Sensations After Breast Cancer Surgery: A 5-Year Comparison of Sentinel Lymph Node Biopsy and Axillary Lymph Node Dissection Roberta H. BaronJane V. FeyKimberly J. Van Zee Breast 13 February 2007 Pages: 1653 - 1661
Diffusion of Surgical Techniques in Early Stage Breast Cancer: Variables Related to Adoption and Implementation of Sentinel Lymph Node Biopsy Kimberly A. VanderveenDebora A. PaternitiRichard J. Bold Breast Oncology 07 February 2007 Pages: 1662 - 1669
Loss of MAL Expression in Precancerous Lesions of the Esophagus Koshi MimoriKohjiro NishidaMasaki Mori OriginalPaper 06 December 2006 Pages: 1670 - 1677
Better Survival in Patients with Esophageal Cancer After Surgical Treatment in University Hospitals: A Plea for Performance by Surgical Oncologists Christian VerhoefRens van de WeyerJohn Th. M. Plukker Gastrointestinal Open access 09 February 2007 Pages: 1678 - 1687
Prognostic Significance of Level and Number of Lymph Node Metastases in Patients with Gastric Cancer Hiroaki SaitoYoji FukumotoMasahide Ikeguchi Gastrointestinal Oncology 24 January 2007 Pages: 1688 - 1693
Detection of Minimal Gastric Cancer Cells in Peritoneal Washings by Focused Microarray Analysis with Multiple Markers: Clinical Implications Kazuhiko MoriTomohiro SuzukiHiroki Sasaki Gastrointestinal Oncology 09 February 2007 Pages: 1694 - 1702
L1 Expression as a Marker for Poor Prognosis, Tumor Progression, and Short Survival in Patients with Colorectal Cancer Yoon-Jung BooJoong-Min ParkHong-Young Moon OriginalPaper 09 January 2007 Pages: 1703 - 1711
Prognostic Significance of Metastatic Lymph Node Ratio in Node-Positive Colon Carcinoma Ho-Young LeeHong-Jo ChoiChoongrak Kim Gastrointestinal Oncology 26 January 2007 Pages: 1712 - 1717
Treatment Failure After Percutaneous Radiofrequency Ablation for Nonsurgical Candidates With Pulmonary Metastases From Colorectal Carcinoma Tristan D. YanJulie KingDavid L. Morris OriginalPaper 07 February 2007 Pages: 1718 - 1726
Can Differences in Bowel Function After Surgery for Rectal Cancer Be Identified by the European Organization for Research and Treatment of Cancer Quality of Life Instrument? Heather B. NeumanDeborah SchragLarissa K. Temple OriginalPaper 30 January 2007 Pages: 1727 - 1734
Carcinoid of the Rectum Risk Stratification (CaRRs): A Strategy for Preoperative Outcome Assessment Bridget N. FahyLaura H. TangMartin R. Weiser OriginalPaper 09 February 2007 Pages: 1735 - 1743
Analysis of Early Postoperative Morbidity Among Patients with Rectal Cancer Treated with and without Neoadjuvant Chemoradiotherapy Victor ValentiJose Luis Hernandez-LizoainJavier A. Alvarez-Cienfuegos Gastrointestinal Oncology 02 March 2007 Pages: 1744 - 1751
Effect of Combined Therapy With Low-Dose 5-Aza-2′-Deoxycytidine and Irinotecan on Colon Cancer Cell Line HCT-15 Megumi IshiguroSatoru IidaKenichi Sugihara OriginalPaper 31 December 2006 Pages: 1752 - 1762
TAT-Bim Induces Extensive Apoptosis in Cancer Cells Hiroyuki KashiwagiJonathan E. McDunnWilliam G. Hawkins Lab Research 06 January 2007 Pages: 1763 - 1771
Clinicopathological Roles of Alterations of Tumor Suppressor Gene p16 in Papillary Thyroid Carcinoma Alfred King Yin LamChung Yau LoJohn M. Luk OriginalPaper 31 December 2006 Pages: 1772 - 1779